Dark

Check out our API

FWBI
First Wave BioPharma, Inc. Common Stock
stock NASDAQ

Inactive

May 16, 2024

2.96USD+4.594%(+0.13)56,525

Pre-market

0.00USD-100.000%(-2.83)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 17, 2022

10:30AM EST FMW Medias New to The Street TV announces the broadcasting of its episodes #292 and #293 of its nationally syndicated shows tonight, Monday, January 17, 2022,at 10:30 PM PT and tomorrow, Tuesday night, January 18, 2022,at 10:30 PM PT on Fox Business Network. GlobeNewswire Inc

Jan 14, 2022

11:25AM EST FMW Medias New to The Street /Newsmax TV announces the broadcasting line-up of its national syndicated 1- hour TV show this Sunday, January 16, 2022, airing time 10-11 AM ET. GlobeNewswire Inc

Jan 13, 2022

11:45AM EST First Wave BioPharma Provides Update On Adrulipase Clinical Program Benzinga

07:00AM EST -- Company filed two provisional patent applications for new enteric granule formulation of adrulipase and for related nutritional indications in new patient populations GlobeNewswire Inc

Jan 7, 2022

01:05PM EST First Wave BioPharma Reports Adjournment Of Its Annual Meeting Benzinga

09:16AM EST First Wave BioPharma Announces Further Adjournment of Annual Meeting GlobeNewswire Inc

Jan 6, 2022

05:21PM EST EXCLUSIVE: First Wave BioPharma CEO Talks COVID-19 Trial, Says 'If The Data Is Positive, I Think The Sky Is The Limit For Our Stock' Benzinga

12:56PM EST First Wave BioPharma CEO Interview On Benzinga's 'Benzinga Live' YouTube Show Concludes Benzinga

12:49PM EST EXCLUSIVE: First Wave BioPharma CEO Says Vaccines Aren't The Answer For COVID, Other Viruses/Diseases, 'They Are Helpful' But Other Treatments Are The Key, Like Therapeutics Benzinga

12:48PM EST EXCLUSIVE: First Wave BioPharma CEO Says 'During H1'22, We'll Have 2 Trials Completing' Benzinga

12:47PM EST EXCLUSIVE: First Wave BioPharma President & CEO, James Sapirstein, Now Interviewing On Benzinga's 'Benzinga Live' YouTube Show, Discussing Co.'s COVID Trial Benzinga

11:59AM EST EXCLUSIVE: First Wave BioPharma President & CEO, James Sapirstein To Appear On Benzinga's Live YouTube TV At 12:45 p.m. ET On Thursday Benzinga

07:02AM EST First Wave BioPharma Completes Enrollment For Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV In COVID-19-Related GI Infections Benzinga

07:00AM EST First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR GlobeNewswire Inc

Jan 4, 2022

07:00AM EST First Wave BioPharma to Participate in Two Investor Conferences in GlobeNewswire Inc

Dec 27, 2021

02:00PM EST FMW Medias New to The Street TV announces the broadcastings of its nationally syndicated shows tonight, Monday, December 27, 2021,at 10:30 PM PST and tomorrow, Tuesday night, December 28, 2021,at 10:30 PM PT on Fox Business Network. GlobeNewswire Inc

Dec 23, 2021

11:45AM EST FMW Medias New to The Street/ Newsmax TV announces the broadcasting line-up of its national syndicated TV show this Sunday, December 26, 2021, airing 1011 A.M. ET. GlobeNewswire Inc

Dec 17, 2021

11:07AM EST EXCLUSIVE: First Wave BioPharma's President & CEO, James Sapirstein To Appear On Benzinga's Live YouTube TV At 12:30 p.m. ET On Friday Benzinga

09:06AM EST First Wave BioPharma Announces Adjournment of Annual Meeting GlobeNewswire Inc

Dec 16, 2021

08:50AM EST Benzinga Pro's Top 5 Stocks To Watch For Thursday, Dec. 16, 2021: RIVN, BCTX, SLNH, SNAX, FWBI Benzinga

Dec 13, 2021

07:00AM EST First Wave BioPharma Chairman and CEO Issues Letter to Shareholders GlobeNewswire Inc

Dec 9, 2021

07:00AM EST First Wave BioPharma Names Brian Feagan, M.D., to Scientific GlobeNewswire Inc

Dec 7, 2021

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021 Benzinga

08:01AM EST Maxim Group Downgrades First Wave BioPharma to Hold Benzinga

Dec 6, 2021

07:00AM EST First Wave BioPharmas CEO and President, James GlobeNewswire Inc

Nov 30, 2021

04:43PM EST First Wave BioPharma Announces Independent Data Monitoring Committee Recommended Enrollment Continue In Part 2 Of COVID-19 RESERVOIR Clinical Trial Of Niclosamide Benzinga

07:37AM EST First Wave BioPharma, Inc. (FWBI) announced Tuesday that an independent data monitoring committee (DMC) has recommended that enrollment continue in Part 2 of the ongoing RESERVOIR Phase 2 trial evaluating FW-COV as a treatment for COVID-19-related gastrointestinal (GI) infections. RTTNews

07:10AM EST First Wave BioPharma Says Independent DMC Recommends Part 2 COVID-19 RESERVOIR Trial Of Niclosamide RTTNews

07:00AM EST First Wave BioPharma Announces Independent Data Monitoring GlobeNewswire Inc

Nov 16, 2021

07:23AM EST First Wave BioPharma Announces Restructuring of Merger Consideration Payment Terms With Former Shareholders of First Wave Bio Benzinga

07:00AM EST First Wave BioPharma Announces Restructuring of Merger GlobeNewswire Inc

Oct 21, 2021

12:11PM EDT Fist Wave BioPharma Reports Formation Of Steering Committee For Phase 2a PASSPORT Trial To Evaluate FW-ICI-AC In Cancer Patients With Immune Checkpoint Inhibitor-Associated Colitis Benzinga

07:30AM EDT First Wave BioPharma Forms Steering Committee for Phase 2a GlobeNewswire Inc

Oct 20, 2021

10:32AM EDT Mid-Morning Market Update: Markets Open Higher; Verizon Posts Upbeat Earnings Benzinga

Oct 19, 2021

09:24AM EDT First Wave BioPharma Announces FDA Clearance of IND Application GlobeNewswire Inc

Oct 14, 2021

09:06AM EDT First Wave BioPharma Announces Dosing Of First Patient In Phase 2b Clinical Trial Evaluating Topical Niclosamide In Patients With Ulcerative Proctitis And Ulcerative Proctosigmoiditis Benzinga

09:00AM EDT First Wave BioPharma Announces Dosing of First Patient in Phase 2b GlobeNewswire Inc

Oct 12, 2021

08:30AM EDT First Wave BioPharma Announces Two Additions to Scientific GlobeNewswire Inc

Oct 5, 2021

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Oct 4, 2021

11:45AM EDT FMW Medias New to The Street TV announces the broadcastings of its national syndicated showstonight, Monday, October 4, 2021at 10:30 PM PT and tomorrow, Tuesday night, October 5, 2021at 10:30 PM PT on Fox Business Network. GlobeNewswire Inc

Oct 1, 2021

12:30PM EDT FMW Medias New to The Street/ Newsmax TV announces the broadcasting line-up of its national syndicated 1-hour TV show this Sunday, October 3, 2021, airing time 10-11 AM ET. GlobeNewswire Inc

07:56AM EDT The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO Benzinga

Sep 30, 2021

07:43AM EDT The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug Benzinga

Sep 29, 2021

08:13AM EDT The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug Benzinga

Sep 28, 2021

08:20AM EDT First Wave BioPharma Begins Patient Screening For Phase 2b Clinical Trial Evaluating Niclosamide In Patients With Ulcerative Proctitis And Ulcerative Proctosigmoiditis Benzinga

08:18AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive Benzinga

08:16AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK To Develop Long-Acting HIV Treatments Benzinga

08:00AM EDT Preliminary data from prior Phase 1a/2a trial indicated safety of topical formulation of FW-UP and suggested possible favorable efficacy GlobeNewswire Inc

Share